Showing results (201-210 of 1,288) with videos related to
Sort By:
Pageof 129
Paediatric Drugs|March 12, 2010
Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemiaCaroline M PerryPaediatric Drugs|December 26, 2009
Adverse effects of immunosuppression in pediatric solid organ transplantationKristine S Schonder, George V Mazariegos, Robert J WeberPaediatric Drugs|November 3, 2009
Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessmentHerbert R Henney, Michael ChezPaediatric Drugs|November 19, 2014
Pediatric clinical drug trials in low-income countries: key ethical issuesS M MacLeod, D C Knoppert, M Stanton-Jean, et al.Paediatric Drugs|March 14, 2016
Pharmacological Management of Childhood-Onset Systemic Lupus ErythematosusColin Thorbinson, Louise Oni, Eve Smith, et al.Paediatric Drugs|November 28, 2015
Recommendations Concerning the First-Line Treatment of Children with TuberculosisNicola Principi, Luisa Galli, Laura Lancella, et al.Paediatric Drugs|December 10, 2015
Emerging Agents for the Management of Nephrotic Syndrome: Progress to DateKeisha L Gibson, Panupong Hansrivijit, Maria E FerrisPaediatric Drugs|December 10, 2015
Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future ImplicationsSeetha M Tamma, Alice J Hsu, Pranita D TammaPaediatric Drugs|December 8, 2017
Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life SettingSerena Pastore, Samuele Naviglio, Arianna Canuto, et al.Pageof 129